Cargando…

Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado

OBJECTIVE: To assess the costs and project the potential lifetime cost-effectiveness of the ongoing Autoimmunity Screening for Kids (ASK) program, a large-scale, presymptomatic type 1 diabetes screening program for children and adolescents in the metropolitan Denver region. RESEARCH DESIGN AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	McQueen, R. Brett, Geno Rasmussen, Cristy, Waugh, Kathleen, Frohnert, Brigitte I., Steck, Andrea K., Yu, Liping, Baxter, Judith, Rewers, Marian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305000/ https://www.ncbi.nlm.nih.gov/pubmed/32327420 http://dx.doi.org/10.2337/dc19-2003

Ejemplares similares

Prevalence of SARS-CoV-2 Antibodies Among Healthy Children From Colorado From 2020 to 2021: A Brief Report
por: Frost, Holly M., et al.
Publicado: (2023)

High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021)

Large-Scale Screening in General Population Children for Celiac Disease with a Multiplex Electrochemiluminescence (ECL) Assay
por: He, Ling, et al.
Publicado: (2020)

Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)
por: Waugh, Kathleen, et al.
Publicado: (2017)

Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA
por: Delling, Francesca N, et al.
Publicado: (2019)

Predictive Modeling of Type 1 Diabetes Stages Using Disparate Data Sources
por: Frohnert, Brigitte I., et al.
Publicado: (2020)

Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis
por: Trogdon, Justin G., et al.
Publicado: (2008)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

Effect of periodontal treatment on diabetes-related healthcare costs: a retrospective study
por: Smits, Kirsten P J, et al.
Publicado: (2020)

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
por: Naylor, Rochelle N., et al.
Publicado: (2014)

Occurrence, mortality and cost of brain disorders in Denmark: a population-based cohort study
por: Vestergaard, Søren Viborg, et al.
Publicado: (2020)

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data
por: Leal, Jose, et al.
Publicado: (2020)

Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study
por: Bächle, C, et al.
Publicado: (2016)

Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness
por: Malo, Jonathan A, et al.
Publicado: (2015)

Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study
por: Krischer, Jeffrey P., et al.
Publicado: (2017)

Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes
por: Nguyen, Huong Q., et al.
Publicado: (2008)

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus
por: Oyagüez, Itziar, et al.
Publicado: (2020)

Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China
por: Li, Yanyun, et al.
Publicado: (2020)

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs
por: Schwab, Phil, et al.
Publicado: (2016)

Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
por: Jodar, Esteban, et al.
Publicado: (2020)

Costs and Savings Associated With Community Water Fluoridation Programs in Colorado
por: Brunson, Diane, et al.
Publicado: (2005)

Case mix, quality, and cost relationships in Colorado nursing homes
por: Schlenker, Robert E., et al.
Publicado: (1984)

The Individual-Level Productivity Costs of Physical Inactivity
por: KARI, JAANA T., et al.
Publicado: (2023)

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA
por: Singhal, Mukul, et al.
Publicado: (2019)

Counting the costs of accreditation in acute care: an activity-based costing approach
por: Mumford, Virginia, et al.
Publicado: (2015)

Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes
por: Espeland, Mark A., et al.
Publicado: (2014)

Editorial: Advancements and challenges in cost and resource allocation: 2022
por: Hafidz, Firdaus, et al.
Publicado: (2023)

Profile, cost and pattern of prescriptions for polymedicated patients in Catalonia, Spain
por: Lizano-Díez, Irene, et al.
Publicado: (2013)

Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City
por: Hernández-Jiménez, Sergio, et al.
Publicado: (2021)

Can peer support be cost saving? An economic evaluation of RAPSID: a randomized controlled trial of peer support in diabetes compared to usual care alone in East of England communities
por: Wingate, La’Marcus, et al.
Publicado: (2017)

Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study
por: Rotondi, Michael A., et al.
Publicado: (2022)

Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes
por: Onengut-Gumuscu, Suna, et al.
Publicado: (2020)

The ethics of aggregation in cost-effectiveness analysis or, “on books, bookshelves, and budget impact”
por: Charlton, Victoria
Publicado: (2022)

The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
por: Zamora, Bernarda, et al.
Publicado: (2023)

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
por: McQueen, R Brett, et al.
Publicado: (2011)

Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
por: Glynn, David, et al.
Publicado: (2022)

Early Infant Diet and Islet Autoimmunity in the TEDDY Study
por: Uusitalo, Ulla, et al.
Publicado: (2018)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Healthcare utilisation and costs for temporomandibular disorders: a descriptive, cross-sectional study
por: Seo, Hyejin, et al.
Publicado: (2020)

Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation
por: Killion, Jordan A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_41oe4acnf8oo06qdc3djod0j07